Publications by authors named "Miriam Segale"

Claim this Profile
T
Tracking the Response to Immunotherapy: Blood microRNA Dynamics in Patients With Advanced Non-Small Cell Lung Cancer.
Maria Vittoria Chiaruttini, Claudia Proto, Giuseppe Lo Russo, Arsela Prelaj, Miriam Segale

JCO Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront blood microRNA test in LDCT-reluctant individuals: insights from the biomild trial.
Gabriella Sozzi, Federica Sabia, Luigi Rolli, Miriam Segale, Paola Suatoni

J Exp Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trial.
Mattia Boeri, Federica Sabia, Roberta E Ledda, Maurizio Balbi, Paola Suatoni, Miriam Segale

Lancet Reg Health Eur· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of (pre)cancerous colorectal lesions in Lynch syndrome patients by microsatellite instability liquid biopsy.
Mattia Boeri, Stefano Signoroni, Chiara Maura Ciniselli, Manuela Gariboldi, Susanna Zanutto, Miriam Segale

Cancer Gene Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer Screening.
Orazio Fortunato, Veronica Huber, Miriam Segale, Agata Cova, Viviana Vallacchi

Cancer Epidemiol Biomarkers Prev· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling.
Daniela Di Paolo, Francesca Pontis, Massimo Moro, Giovanni Centonze, Giulia Bertolini, Miriam Segale

Mol Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320.
Francesca Pontis, Luca Roz, Mavis Mensah, Miriam Segale, Massimo Moro

J Exp Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-Related Alterations in Immune Contexture Are Associated with Aggressiveness in Rhabdomyosarcoma.
Patrizia Gasparini, Orazio Fortunato, Loris De Cecco, Michela Casanova, Maria Federica Iannó, Miriam Segale

Cancers (Basel)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis